{
    "Trade/Device Name(s)": [
        "Chromopep PC 2.5",
        "Chromopep PC 5",
        "Chromopep AT 2.5",
        "Chromopep AT 5"
    ],
    "Submitter Information": "Horiba ABX",
    "510(k) Number": "K050448",
    "Predicate Device Reference 510(k) Number(s)": [
        "K023990",
        "K023991"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GCP",
        "JBQ"
    ],
    "Summary Letter Date": "September 2, 2005",
    "Summary Letter Received Date": "September 6, 2005",
    "Submission Date": "February 16, 2005",
    "Regulation Number(s)": [
        "21CFR864.7290",
        "21CFR864.7060"
    ],
    "Regulation Name(s)": [
        "Test, Quantitative factor deficiency",
        "Antithrombin quantitation"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Protein C",
        "Antithrombin"
    ],
    "Specimen Type(s)": [
        "Citrated human plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Chromogenic assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Horiba ABX Chromopep PC and Chromopep AT chromogenic assays for quantitative determination of Protein C and Antithrombin activity in citrated human plasma.",
    "Indications for Use Summary": "Intended for use as in vitro chromogenic assays for quantitative determination of Protein C and Antithrombin activity in citrated human plasma.",
    "fda_folder": "Hematology"
}